# US 2021/0330595 A1 · Non-digestible capsules for the delivery of fluid absorbing materials

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330595 A1
- Document ID: US20210330595A1
- Status: Published application
- Kind: A1
- Application number: 17/366,863
- Filed: 2021-07-02
- Published: 2021-10-28
- Earliest claimed: 2011-08-01
- Assignees: Hb Biotechnologies Corporation
- Applicants: HB Biotechnologies Corporation
- Inventors: Danielle BERGER
- Web page: https://patentgrep.com/patent/US20210330595A1

## CPC

- A61K 9/4866: {Organic macromolecular compounds}
- A61K 9/4808: {characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release (capsules filled with granules or microparticles A61K9/16; filled with microcapsules or coated microparticles A61K9/50; with mixture of different granules, microcapsules, (coated) microparticles A61K9/5084)}
- A61K 31/721: Dextrans
- A61K 31/738: Cross-linked polysaccharides
- A61P 1/10: Laxatives
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/06: Antihyperlipidemics
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 7/08: Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P27/04)
- A61P 7/10: Antioedematous agents; Diuretics
- A61P 13/12: of the kidneys
- A61P 39/02: Antidotes
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to a product, method of use, and/or method of preparing a capsule or capsular like product that comprises hydrophilic fluid-absorbing materials that bind, entrap, and/or absorb large quantities of fluid. The capsules or capsular like product may be capable of diverting the mode of fluid and waste elimination from the renal route to the gastrointestinal route.

## Claims

### Claim at position 1

-64. (canceled)

### Claim 65

An orally consumable medical product comprising a capsule constructed of substantially nitrogen-free material, comprising less than 4% nitrogen, wherein the capsule contains a water-insoluble fluid-absorbing material having the capacity of absorbing in the range from its own weight up to 50 times its own weight or more.

### Claim 66 (depends on 65)

A product of claim 65, wherein the capsules are made from non-animal and/or non-protein based material, wherein the capsule materials contain no protein.

### Claim 67 (depends on 65)

The product of claim 65, wherein the capsule comprises a singular opening, preferably at the distal end of the capsule, sealed with a hydrogel plug, optionally made of polymethacrylates, hydropropylmethyl cellulose, polyvinyl alcohol, polyvinyl acetate, polyethylene oxide, saturated polyglycolated glycerides, glyceryl monooleates, pectin, sodium polyacrylate, acrylate polymers, copolymers with an abundance of hydrophilic groups, agarose, methylcellulose, hyaluronan, and other naturally derived polymers, optionally wherein the hydrogel plug swells, erodes, congeals, melts, engymatically erodes, or a combination thereof.

### Claim 68 (depends on 65)

The product of claim 65, wherein release of the water insoluble fluid-absorbing material from the capsule is pH dependent, at a pH of 1 to 3, and/or at a pH of 5 to 8.

### Claim 69 (depends on 65)

The product of claim 65, wherein the capsule is a two piece capsule.

### Claim 70 (depends on 65)

The product of claim 65, wherein the capsule is constructed of natural vegetable-derived polysaccharide, said polysaccharide optionally being hypromellose, cellulose, alginate, or a biodegradable carbohydrate or a combination thereof, or rubber, silicone rubber, or gelatinous material.

### Claim 71 (depends on 65)

The product of claim 65, wherein the fluid-absorbing material is a hydrophilic fiber, powder, gel, or grain; or wherein the fluid-absorbing material is an insoluble, cross-linked polysaccharide, optionally nitrogen-free in pH ranging from about 1 to about 8; or wherein the fluid-absorbing material is non-ionic and further comprises a high content of hydroxyl groups.

### Claim 72 (depends on 65)

The product of claim 65, wherein the fluid-absorbing material is dextran, preferably a modified dextran, wherein the modified dextran is optionally cross linked with epichlorohydrin; modified starches; dextrin; cellulose; polyglucose; or product obtained by partial depolymerization; or combination thereof.

### Claim 73 (depends on 65)

The product of claim 65, wherein the fluid-absorbing material is a copolymer in the form of a gel grain comprising a three dimensional network of dextran substances, said dextran substances optionally comprising α-1,6-glucosidically bonded glucose residues having general formula —R—O—Xn—O—R, wherein R is a dextran substance, X is an aliphatic radical with carbon, n is 3-10; and/or α-1,6-glucosidically bonded glucose residues linked by either bridges.

### Claim 74 (depends on 65)

The product of claim 65, wherein the fluid-absorbing material comprises a water regain in the range of 1 to 100 grams/dry gram of dry product, or a water regain of 1 to 85 grams/dry grams of dry product, and optionally wherein the fluid-absorbing material is a particle size ranging from 50 to 200 mesh.

### Claim 75 (depends on 65)

A method of preparing an orally consumable medical product according to claim 65, said method comprising encapsulating a fluid absorbing polymer comprising:
a. filling a capsule constructed of substantially nitrogen-free material, comprising less than 4% nitrogen, with a fluid absorbing material; and
b. sealing or enclosing the capsule, whereby the capsule encapsulates the fluid absorbing material.

### Claim 76

A method of treating a disease or disorder selected from renal failure, obesity, constipation, hyperkalemia, uremia, hyperammonemia, non-insulin dependent diabetes or combinations thereof, comprising administering one or more capsules constructed of substantially nitrogen-free material, comprising less than 4% nitrogen, wherein the capsule contains a water-insoluble, fluid-absorbing material.

### Claim 77 (depends on 76)

The method according to claim 76, wherein said administration induces a sense of fullness, reduces the frequency of dialysis, removes excess accumulation of serum toxins, and/or reduces triglycerides.
